Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biomea Fusion Inc (NQ: BMEA )

8.990 +0.300 (+3.45%)
Streaming Delayed Price Updated: 1:47 PM EDT, Sep 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Biomea Fusion Inc

< Previous 1 2 3 4 5 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
BMEA Stock Earnings: Biomea Fusion Beats EPS for Q2 2024
BMEA stock results show that Biomea Fusion beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Recap: Biomea Fusion Q4 Earnings
Via Benzinga
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
This Cleveland-Cliffs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
Crude Oil Edges Lower; Asensus Surgical Shares Jump
Via Benzinga
Exposures Fossil Fuels
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Gold Falls Sharply; Geron Shares Spike Higher
Via Benzinga
Why Biomea Fusion (BMEA) Stock Is Down 60%
Biomea Fusion shares are trading lower by 62.7% during Friday's session. The company received notice from the FDA that Its trials of BMF-219 have been placed on clinical hold. 
Via Benzinga
Exposures Product Safety
US Stocks Lower; Nonfarm Payrolls Increase More Than Expected
Via Benzinga
Biomea Fusion Crashes 65% After FDA Puts Diabetes Treatment Studies On Hold
The FDA cited concerns of liver toxicity, but the company says its drug has been generally well-tolerated. 
Via Investor's Business Daily
Exposures Product Safety
Why Is Virax Biolabs (VRAX) Stock Down 15% Today?
Virax Biolabs stock is down on Friday as shares of VRAX come off of a massive rally yesterday that didn't come with any news. 
Via InvestorPlace
Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Why Is Biomea Fusion (BMEA) Stock Down 63% Today?
Biomea Fusion stock is falling on Friday after investors learned of the FDA placing a clinical hold on its Phase I/II clinical trials. 
Via InvestorPlace
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning! 
Via InvestorPlace
This Pharma Stock Dropped 60% Premarket As FDA Halted Diabetes Drug Trials
Elevated liver enzyme levels were noted, although most adverse events were mild to moderate, with no severe reactions reported. 
Via Benzinga
Exposures Product Safety
Ride the Gamma Wave: 3 Stocks on the Verge of a Short Squeeze
Though short squeezes are never guaranteed, these three potential short squeeze stocks could provide generous returns if bought right. 
Via InvestorPlace
Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Short Squeeze Specialists: 3 Stocks With the Expertise to Defy Bearish Expectations
Sometimes the bears can push their luck too much, leading to a reverse response. That’s the incentive behind these short squeeze stocks. 
Via InvestorPlace
BMEA Stock Earnings: Biomea Fusion Misses EPS for Q1 2024
BMEA stock results show that Biomea Fusion missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
BMEA Stock Earnings: Biomea Fusion Misses EPS for Q4 2023
BMEA stock results show that Biomea Fusion missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode
Bullish speculators could have their opportunity to blow up the bears with these short-squeeze stocks to buy. 
Via InvestorPlace
Feeling Shut Out? 3 Sizzling Stocks and the Pull-Back Prices to Watch For
Although FOMO can burn, investors will want to be careful with these stock prices to watch as a little patience can go a long way. 
Via InvestorPlace
3 Speculative Stocks That Could Make Your February Unforgettable
Gambling isn’t for everyone. However, if you’re dead set on speculative stocks, these ideas could shift the odds in your favor. 
Via InvestorPlace
3 Long-Term Stocks to Buy on the Dip: February 2024
Although these ideas might not be the most exciting in the market, their predictability makes them excellent long-term stocks to buy. 
Via InvestorPlace
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.